Lörsch Alisa Martina, Jung Johannes, Lange Sebastian, Pfarr Nicole, Mogler Carolin, Illert Anna Lena
Zentrum für Personalisierte Medizin (ZPM), Klinikum rechts der Isar, Technische Universität München, Ismaninger Str. 22, 81675, München, Deutschland.
Klinik und Poliklinik für Innere Medizin III, Hämatologie und Onkologie, Klinikum rechts der Isar, Technische Universität München, München, Deutschland.
Pathologie (Heidelb). 2024 May;45(3):180-189. doi: 10.1007/s00292-024-01315-8. Epub 2024 Apr 3.
Due to the considerable technological progress in molecular and genetic diagnostics as well as increasing insights into the molecular pathogenesis of diseases, there has been a fundamental paradigm shift in the past two decades from a "one-size-fits-all approach" to personalized, molecularly informed treatment strategies. Personalized medicine or precision medicine focuses on the genetic, physiological, molecular, and biochemical differences between individuals and considers their effects on the development, prevention, and treatment of diseases. As a pioneer of personalized medicine, the field of oncology is particularly noteworthy, where personalized diagnostics and treatment have led to lasting change in the treatment of cancer patients in recent years. In this article, the significant change towards personalized treatment concepts, especially in the field of personalized oncology, will be discussed and examined in more detail.
由于分子和基因诊断技术取得了长足进步,以及对疾病分子发病机制的认识不断加深,在过去二十年中出现了根本性的范式转变,从“一刀切的方法”转向个性化的、基于分子信息的治疗策略。个性化医疗或精准医疗关注个体之间的基因、生理、分子和生化差异,并考虑这些差异对疾病发生、预防和治疗的影响。作为个性化医疗的先驱,肿瘤学领域尤为值得关注,近年来,个性化诊断和治疗给癌症患者的治疗带来了持久变革。本文将更详细地讨论和审视向个性化治疗理念的重大转变,尤其是在个性化肿瘤学领域。